Understanding MCP‐MOD dose finding as a method based on linear regression
MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple‐comparison procedure is applied that controls the alpha level for the family of null hypotheses associated wi...
Saved in:
| Published in | Statistics in medicine Vol. 36; no. 27; pp. 4401 - 4413 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
England
Wiley Subscription Services, Inc
30.11.2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0277-6715 1097-0258 1097-0258 |
| DOI | 10.1002/sim.7424 |
Cover
| Abstract | MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple‐comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of “good” candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency.
The MCP‐MOD procedure can be alternatively represented as a method based on simple linear regression, where “simple” refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness‐of‐fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data‐based model selection. |
|---|---|
| AbstractList | MCP-MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple-comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of "good" candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP-MOD procedure can be alternatively represented as a method based on simple linear regression, where "simple" refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness-of-fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data-based model selection. MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple‐comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of “good” candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP‐MOD procedure can be alternatively represented as a method based on simple linear regression, where “simple” refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness‐of‐fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data‐based model selection. MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple‐comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of “good” candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP‐MOD procedure can be alternatively represented as a method based on simple linear regression, where “simple” refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness‐of‐fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data‐based model selection. MCP-MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple-comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of "good" candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP-MOD procedure can be alternatively represented as a method based on simple linear regression, where "simple" refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness-of-fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data-based model selection.MCP-MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate dose response models. A multiple-comparison procedure is applied that controls the alpha level for the family of null hypotheses associated with the contrasts. Provided at least one contrast is significant, a corresponding set of "good" candidate models is identified. The model generating the most significant contrast is typically selected. There have been numerous publications on the method. It was endorsed by the European Medicines Agency. The MCP-MOD procedure can be alternatively represented as a method based on simple linear regression, where "simple" refers to the inclusion of an intercept and a single predictor variable, which is a transformation of dose. It is shown that the contrasts are equal to least squares linear regression slope estimates after a rescaling of the predictor variables. The test for each contrast is the usual t statistic for a null slope parameter, except that a variance estimate with fewer degrees of freedom is used in the standard error. Selecting the model corresponding to the most significant contrast P value is equivalent to selecting the predictor variable yielding the smallest residual sum of squares. This criteria orders the models like a common goodness-of-fit test, but it does not assure a good fit. Common inferential methods applied to the selected model are subject to distortions that are often present following data-based model selection. |
| Author | Thomas, Neal |
| Author_xml | – sequence: 1 givenname: Neal orcidid: 0000-0002-1915-8487 surname: Thomas fullname: Thomas, Neal email: snthomas99@gmail.com |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28879676$$D View this record in MEDLINE/PubMed |
| BookMark | eNp10c1O3DAQB3ALUZWFVuIJkCUuvWQ7dmJPckRLP1BZUanlbDnJGIwSG-ysKm59hD5jn6ShC0Wq2tNI1s-jmfnvs90QAzF2KGApAOTb7MclVrLaYQsBDRYgVb3LFiARC41C7bH9nG8AhFASX7I9WdfYaNQL9uky9JTyZEPvwxVfrz7__P5jfXHK-5iJO799tplbPtJ0HXve2kw9j4EPPpBNPNFVopx9DK_YC2eHTK8f6wG7fP_u6-pjcX7x4Wx1cl50ZdVUhSJrsVGlK7EnVbWdQGpqp6HusENUAI11ogdXt1WlGgWyk-BaqpGgdALKA_Zm2_c2xbsN5cmMPnc0DDZQ3GQjmlJrKTVWMz3-i97ETQrzdLPSgFqC1rM6elSbdqTe3CY_2nRvns40g-UWdCnmnMiZzk92mneekvWDEWAecjBzDuYhh-cR_3x46vkPWmzpNz_Q_X-d-XK2_u1_AQw6lMs |
| CitedBy_id | crossref_primary_10_1002_sim_8444 crossref_primary_10_1111_biom_13442 crossref_primary_10_1002_pst_2428 crossref_primary_10_1016_j_cct_2022_106957 crossref_primary_10_1136_bmjopen_2023_079158 crossref_primary_10_1002_bimj_202100044 |
| Cites_doi | 10.1177/0049124104268644 10.1111/biom.12563 10.1080/19466315.2014.924876 10.1007/978-1-4757-3294-8 10.1080/10543400600860428 10.1080/19466315.2016.1256229 10.1111/biom.12357 10.1111/j.1541-0420.2005.00344.x 10.1002/sim.6052 10.1002/9781118625590 10.1002/pst.1693 10.1007/978-3-642-01689-9 10.1080/10543400600860469 10.1017/CBO9780511546822 10.2307/2529336 10.1002/bimj.4710270104 |
| ContentType | Journal Article |
| Copyright | Copyright © 2017 John Wiley & Sons, Ltd. |
| Copyright_xml | – notice: Copyright © 2017 John Wiley & Sons, Ltd. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
| DOI | 10.1002/sim.7424 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) CrossRef MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Statistics Public Health |
| EISSN | 1097-0258 |
| EndPage | 4413 |
| ExternalDocumentID | 28879676 10_1002_sim_7424 SIM7424 |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .GA 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABOCM ABPVW ACAHQ ACCFJ ACCZN ACGFS ACPOU ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB BAFTC BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P G-S G.N GNP GODZA H.T H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SUPJJ SV3 TN5 UB1 V2E W8V W99 WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRC WUP WWH WXSBR WYISQ XBAML XG1 XV2 ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY AMVHM CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
| ID | FETCH-LOGICAL-c3494-5eaa7953f37de54bc17e98f608c7c775009af1d0f8b4459502c20fbe87e03f103 |
| IEDL.DBID | DR2 |
| ISSN | 0277-6715 1097-0258 |
| IngestDate | Thu Jul 10 19:19:02 EDT 2025 Tue Oct 07 05:51:23 EDT 2025 Wed Feb 19 02:40:42 EST 2025 Wed Oct 01 04:09:03 EDT 2025 Thu Apr 24 23:03:37 EDT 2025 Wed Jan 22 16:21:25 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 27 |
| Keywords | emax weighted least squares (WLS) regression dose response MCP-MOD |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor Copyright © 2017 John Wiley & Sons, Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3494-5eaa7953f37de54bc17e98f608c7c775009af1d0f8b4459502c20fbe87e03f103 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-1915-8487 |
| PMID | 28879676 |
| PQID | 1960762066 |
| PQPubID | 48361 |
| PageCount | 13 |
| ParticipantIDs | proquest_miscellaneous_1936622674 proquest_journals_1960762066 pubmed_primary_28879676 crossref_citationtrail_10_1002_sim_7424 crossref_primary_10_1002_sim_7424 wiley_primary_10_1002_sim_7424_SIM7424 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 30 November 2017 |
| PublicationDateYYYYMMDD | 2017-11-30 |
| PublicationDate_xml | – month: 11 year: 2017 text: 30 November 2017 day: 30 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: New York |
| PublicationTitle | Statistics in medicine |
| PublicationTitleAlternate | Stat Med |
| PublicationYear | 2017 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2017; 73 1976; 32 2004; 33 2015; 14 2015; 71 2000 2006; 16 2017; 35 2009 1998 1977; 4 2006 2016 2015 2005; 61 2002 2014; 6 2014; 33 1985; 27 1988 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 Cox D (e_1_2_7_17_1) 1977; 4 e_1_2_7_19_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_25_1 e_1_2_7_13_1 Robertson T (e_1_2_7_23_1) 1988 e_1_2_7_24_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_22_1 e_1_2_7_10_1 Burnham K (e_1_2_7_18_1) 2002 e_1_2_7_21_1 e_1_2_7_20_1 |
| References_xml | – year: 2009 – volume: 6 start-page: 302 issue: 4 year: 2014 end-page: 317 article-title: Meta‐analysis of clinical dose‐response in a large drug development portfolio publication-title: Stat Biopharma Res – year: 2002 – volume: 32 start-page: 1 year: 1976 end-page: 49 article-title: The analysis and selection of variables in linear regression publication-title: Biometrics – volume: 35 start-page: 137 issue: 17 year: 2017 end-page: 146 article-title: Analysis of clinical dose‐response in small‐molecule drug development: 2009‐2014 publication-title: Statistics in Biopharmaceutical Research – year: 1988 – volume: 16 start-page: 639 year: 2006 end-page: 656 article-title: Design and analysis of dose finding studies combining multiple comparisons and modeling procedures publication-title: J Biopharm Stat – year: 2006 – volume: 71 start-page: 996 year: 2015 end-page: 1008 article-title: Dose response signal detection under model uncertainty publication-title: Biometrics – volume: 14 start-page: 359 year: 2015 end-page: 367 article-title: Characterization of dose‐response for count data using a generalized MCP‐Mod approach in an adaptive dose‐ranging trial publication-title: Pharma Stat – year: 2000 – volume: 33 start-page: 261 year: 2004 end-page: 304 article-title: Multimodel inference: understanding AIC and BIC in model selection publication-title: Socio Methods Res – volume: 33 start-page: 1646 year: 2014 end-page: 1661 article-title: Model‐based dose finding under model uncertainty using general parametric models publication-title: Stat Med – volume: 61 start-page: 738 year: 2005 end-page: 748 article-title: Combining multiple comparisons and modeling techniques in dose‐response studies publication-title: Biometrics – volume: 16 start-page: 657 year: 2006 end-page: 677 article-title: Hypothesis testing and Bayesian estimation using a sigmoid model applied to sparse dose‐response designs publication-title: J Biopharma Stat – volume: 73 start-page: 197 issue: 1 year: 2017 end-page: 205 article-title: Likelihood ratio tests for a dose‐response effect using multiple nonlinear regression models publication-title: Biometrics – volume: 4 start-page: 49 year: 1977 end-page: 70 article-title: The role of significance tests publication-title: Scand J Stat – year: 2016 – volume: 27 start-page: 25 year: 1985 end-page: 38 article-title: The application of Hunter's inequality in simultaneous testing publication-title: Biom J – year: 2015 – year: 1998 – ident: e_1_2_7_19_1 doi: 10.1177/0049124104268644 – ident: e_1_2_7_5_1 doi: 10.1111/biom.12563 – ident: e_1_2_7_13_1 doi: 10.1080/19466315.2014.924876 – ident: e_1_2_7_2_1 – ident: e_1_2_7_16_1 doi: 10.1007/978-1-4757-3294-8 – ident: e_1_2_7_6_1 doi: 10.1080/10543400600860428 – ident: e_1_2_7_21_1 doi: 10.1080/19466315.2016.1256229 – ident: e_1_2_7_4_1 doi: 10.1111/biom.12357 – ident: e_1_2_7_14_1 – volume: 4 start-page: 49 year: 1977 ident: e_1_2_7_17_1 article-title: The role of significance tests publication-title: Scand J Stat – ident: e_1_2_7_11_1 – ident: e_1_2_7_3_1 doi: 10.1111/j.1541-0420.2005.00344.x – ident: e_1_2_7_7_1 doi: 10.1002/sim.6052 – ident: e_1_2_7_25_1 doi: 10.1002/9781118625590 – ident: e_1_2_7_8_1 doi: 10.1002/pst.1693 – ident: e_1_2_7_10_1 doi: 10.1007/978-3-642-01689-9 – ident: e_1_2_7_12_1 doi: 10.1080/10543400600860469 – ident: e_1_2_7_9_1 – ident: e_1_2_7_24_1 doi: 10.1017/CBO9780511546822 – volume-title: Model Selection and Multimodel Inference: A Practical Information‐Theoretic Approach year: 2002 ident: e_1_2_7_18_1 – volume-title: Order Restricted Statistical Inference year: 1988 ident: e_1_2_7_23_1 – ident: e_1_2_7_20_1 doi: 10.2307/2529336 – ident: e_1_2_7_15_1 – ident: e_1_2_7_22_1 doi: 10.1002/bimj.4710270104 |
| SSID | ssj0011527 |
| Score | 2.26537 |
| Snippet | MCP‐MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate... MCP-MOD is a testing and model selection approach for clinical dose finding studies. During testing, contrasts of dose group means are derived from candidate... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 4401 |
| SubjectTerms | dose response Dose-Response Relationship, Drug Drug dosages emax Humans Linear Models MCP‐MOD Medical statistics Models, Statistical Pharmaceutical Preparations - administration & dosage Regression analysis weighted least squares (WLS) regression |
| Title | Understanding MCP‐MOD dose finding as a method based on linear regression |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsim.7424 https://www.ncbi.nlm.nih.gov/pubmed/28879676 https://www.proquest.com/docview/1960762066 https://www.proquest.com/docview/1936622674 |
| Volume | 36 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: Mathematics Source customDbUrl: eissn: 1097-0258 dateEnd: 20241105 omitProxy: false ssIdentifier: ssj0011527 issn: 0277-6715 databaseCode: AMVHM dateStart: 20120220 isFulltext: true titleUrlDefault: https://www.ebsco.com/products/research-databases/mathematics-source providerName: EBSCOhost – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0277-6715 databaseCode: DR2 dateStart: 19960101 customDbUrl: isFulltext: true eissn: 1097-0258 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011527 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6hHlAlVGBL24VSGakqp2wdJ7aTY1VYLaC0FbBSJQ6RE9sVos2ize6FE4_AM_IkHcdJ-gOVqp4iJRPH8XjGnz32NwC7luuUK6sDa4wIYsXTIOW0DJhWTFiFAN-6iG52JCbT-OMpP213VbqzMJ4fol9wc5bR-Gtn4Kqo969IQ-vvFyOc1zkq0DASzWzqc88cFXbZWl2EUsiQd7yzlO13L94cif6BlzfRajPcjJ_Ct66ifpfJj9FyUYzKX7c4HB_2J89grUWh5MB3m-fwyFQDeJy1cfYBPPGrecQfUhrAqsOkntJ5HT5Nrx-IIdnhyd_ff7Ljd0TPakOaIDjeVjVRxOenJm6o1GRWEVdXNSdzc-a331YvYDp-__VwErQ5GYLSEdkE3CglUx7ZSGrD46IMpUF9CpqUspQIP2iqbKipTYo45qh2VjJqC5NIQyMb0mgDVqpZZbaAJJwJSTVNjNDoroVikoaJsJaxIlaGD-Ftp5-8bAnLXd6M89xTLbMcGy53DTeEN73kT0_S8R-Z7U7FeWumdY7uh-JogLALi-gfo4G5qImqzGzpZCIhEKRKLGLTd43-IwxddIpVH8Jeo-A7v55_-ZC568v7Cr6CVeYAREMyuQ0ri_nSvEb4syh2mo5-Cez0AAM |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9UwFD9BTJCEoFxRr6LWxMDTLl23tlt4Mii5CEOj3IQHkqVbW2PUXXL_vPDER_Az8kk4XbcB_kmMT0u2s67r6Tn9taf9HYDXluuUK6sDa4wIYsXTIOW0DJhWTFiFAN-6iG52JIaj-P0JP1mAnfYsjOeH6BbcnGXU_toZuFuQ3r5mDZ1-_THAiV18B-7GAqcpDhF96rijwjZfq4tRChnylnmWsu32zdtj0W8A8zZerQecvftw2lbV7zP5NpjPikF5_guL43_-ywNYbYAoeeN7zhosmKoHS1kTau_Bil_QI_6cUg-WHSz1rM4P4WB080wMyXY_Xl78zD68JXo8NaSOg-NtNSWK-BTVxI2Wmowr4iqrJmRivvgduNU6jPbeHe8OgyYtQ1A6LpuAG6VkyiMbSW14XJShNKhSQZNSlhIRCE2VDTW1SRHHHDXPSkZtYRJpaGRDGj2CxWpcmSdAEs6EpJomRmj02EIxScNEWMtYESvD-7DVKigvG85ylzrje-7ZllmODZe7huvDq07yzPN0_EFmo9Vx3ljqNEcPRHFAQOSFRXSP0cZc4ERVZjx3MpEQiFMlFvHY943uIwy9dIpV78NmreG_fj3_vJ-569N_FXwJ94bH2WF-uH908AyWmcMTNefkBizOJnPzHNHQrHhR9_or-C0EJA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VVqoqoQILLVsKGAnRU7aOE9uJOKFuVy0lpSpdqYdKkRPbCEGz1f5ceuIReEaehHGcBEpBQpwiJRPb8XjGXzz2NwAvLdcpV1YH1hgRxIqnQcppGTCtmLAKAb51Ed3sWByM47fn_HwJXrdnYTw_RLfg5iyj9tfOwM2Vtrs_WUNnny4H-GMX34GVmKeJ2883PO24o8I2X6uLUQoZ8pZ5lrLd9s2bc9EtgHkTr9YTzugeXLRN9ftMPg8W82JQXv_G4vif33If1hsgSt74kfMAlkzVg9WsCbX34K5f0CP-nFIP1hws9azOD-Fo_OuZGJLtnXz_-i17PyR6MjOkjoPjbTUjivgU1cTNlppMKuIaq6Zkaj76HbjVIxiP9s_2DoImLUNQOi6bgBulZMojG0lteFyUoTSoUkGTUpYSEQhNlQ01tUkRo2I4ZSWjtjCJNDSyIY02YLmaVOYxkIQzIammiREaPbZQTNIwEdYyVsTK8D7stArKy4az3KXO-JJ7tmWWY8flruP68KKTvPI8HX-Q2W51nDeWOsvRA1GcEBB5YRHdY7QxFzhRlZksnEwkBOJUiUVs-rHRVcLQS6fY9D68qjX819rzD4eZu279q-BzWD0ZjvJ3h8dHT2CNOThRU05uw_J8ujBPEQzNi2f1oP8BmpYDqA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Understanding+MCP%E2%80%90MOD+dose+finding+as+a+method+based+on+linear+regression&rft.jtitle=Statistics+in+medicine&rft.au=Thomas%2C+Neal&rft.date=2017-11-30&rft.issn=0277-6715&rft.eissn=1097-0258&rft.volume=36&rft.issue=27&rft.spage=4401&rft.epage=4413&rft_id=info:doi/10.1002%2Fsim.7424&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_sim_7424 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-6715&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-6715&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-6715&client=summon |